356 related articles for article (PubMed ID: 30033874)
1. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
Tang C; Zhu G
Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
[TBL] [Abstract][Full Text] [Related]
2. Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.
Sun H; Xu XY; Tian XL; Shao HT; Wu XD; Wang Q; Su X; Shi Y
Immunobiology; 2014 Jan; 219(1):25-36. PubMed ID: 23886693
[TBL] [Abstract][Full Text] [Related]
3. NF-κB in cancer therapy.
Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
6. NF-κB signaling in cancer stem cells: a promising therapeutic target?
Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis.
Morgan D; Garg M; Tergaonkar V; Tan SY; Sethi G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188449. PubMed ID: 33058996
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership.
Dobrovolskaia MA; Kozlov SV
Curr Cancer Drug Targets; 2005 Aug; 5(5):325-44. PubMed ID: 16101381
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB as a potential molecular target for cancer therapy.
Lee CH; Jeon YT; Kim SH; Song YS
Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
[TBL] [Abstract][Full Text] [Related]
10. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
Zeng KW; Wang S; Dong X; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2014 Mar; 275(3):244-56. PubMed ID: 24486434
[TBL] [Abstract][Full Text] [Related]
11. 1-(2,3-Dibenzimidazol-2-ylpropyl)-2-methoxybenzene Is a Syk Inhibitor with Anti-Inflammatory Properties.
Kim E; Son YJ; Yang Y; Shen T; Kim I; Aravinthan A; Kim JH; Cho JY
Molecules; 2016 Apr; 21(4):508. PubMed ID: 27096863
[TBL] [Abstract][Full Text] [Related]
12. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
Razani B; Reichardt AD; Cheng G
Immunol Rev; 2011 Nov; 244(1):44-54. PubMed ID: 22017430
[TBL] [Abstract][Full Text] [Related]
13. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
Yu L; Li L; Medeiros LJ; Young KH
Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B signaling and carcinogenesis.
Okamoto T; Sanda T; Asamitsu K
Curr Pharm Des; 2007; 13(5):447-62. PubMed ID: 17348842
[TBL] [Abstract][Full Text] [Related]
15. Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells.
Yang WS; Chang JW; Han NJ; Lee SK; Park SK
Exp Cell Res; 2012 Sep; 318(15):1867-76. PubMed ID: 22659134
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNAs Regulating NF-κB Signaling.
Li M; Guan H
Adv Exp Med Biol; 2016; 927():317-36. PubMed ID: 27376741
[TBL] [Abstract][Full Text] [Related]
17. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
Fouani L; Kovacevic Z; Richardson DR
Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
[TBL] [Abstract][Full Text] [Related]
18. The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages.
Li C; Xue VW; Wang QM; Lian GY; Huang XR; Lee TL; To KF; Tang PM; Lan HY
Cancer Immunol Res; 2020 Aug; 8(8):1004-1017. PubMed ID: 32532809
[TBL] [Abstract][Full Text] [Related]
19. microRNA and NF-kappa B.
Yuan Y; Tong L; Wu S
Adv Exp Med Biol; 2015; 887():157-70. PubMed ID: 26662991
[TBL] [Abstract][Full Text] [Related]
20. Roles of the NF-κB Pathway in B-Lymphocyte Biology.
Sasaki Y; Iwai K
Curr Top Microbiol Immunol; 2016; 393():177-209. PubMed ID: 26275874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
